Financhill
Back

Viking Therapeutics Stock Price Chart

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VKTX is experiencing slight selling pressure.

Viking Therapeutics Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 27.14 Buy
20-day SMA: 27.4 Buy
50-day SMA: 26.07 Buy
200-day SMA: 43.06 Sell
8-day EMA: 27.28 Buy
20-day EMA: 27.23 Buy
50-day EMA: 27.55 Buy
200-day EMA: 37.08 Sell

Viking Therapeutics Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.09 Buy
Relative Strength Index (14 RSI): 52.18 Buy
Chaikin Money Flow: -415651 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (26.78 - 28.22) Buy
Bollinger Bands (100): (25 - 31.9) Sell

Viking Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Viking Therapeutics Stock

Is Viking Therapeutics Stock a Buy?

VKTX Technical Analysis vs Fundamental Analysis

Sell
40
Viking Therapeutics (VKTX) is a Sell

Is Viking Therapeutics a Buy or a Sell?

Viking Therapeutics Stock Info

Market Cap:
3.1B
Price in USD:
27.57
Share Volume:
3.6M

Viking Therapeutics 52-Week Range

52-Week High:
81.73
52-Week Low:
18.92
Sell
40
Viking Therapeutics (VKTX) is a Sell

Viking Therapeutics Share Price Forecast

Is Viking Therapeutics Stock a Buy?

  • Viking Therapeutics share price is 27.57 while VKTX 8-day exponential moving average is 27.28, which is a Buy signal.
  • The stock price of VKTX is 27.57 while Viking Therapeutics 20-day EMA is 27.23, which makes it a Buy.
  • Viking Therapeutics 50-day exponential moving average is 27.55 while VKTX share price is 27.57, making it a Buy technically.
  • VKTX stock price is 27.57 and Viking Therapeutics 200-day simple moving average is 37.08, creating a Sell signal.

Fundamental Analysis of Viking Therapeutics

Is Viking Therapeutics a good investment?

  • Analysts estimate an earnings decrease this quarter of $0.24 per share, a decrease next quarter of $0.23 per share, a decrease this year of $0.88 per share, and a decrease next year of $0.64 per share.

Technical Analysis of Viking Therapeutics

Should I short Viking Therapeutics stock?

* Viking Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.